These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29948903)

  • 1. Episodic memory decline in Parkinson' s disease: relation with white matter hyperintense lesions and influence of quantification method.
    Dunet V; Fartaria MJ; Deverdun J; Le Bars E; Maury F; Castelnovo G; Kober T; Cuadra MB; Geny C; Marechal B; de Champfleur NM
    Brain Imaging Behav; 2019 Jun; 13(3):810-818. PubMed ID: 29948903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Arlt S; Buchert R; Spies L; Eichenlaub M; Lehmbeck JT; Jahn H
    Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):335-44. PubMed ID: 22940716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
    Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic Resonance Imaging-Visible Perivascular Spaces in Basal Ganglia Predict Cognitive Decline in Parkinson's Disease.
    Park YW; Shin NY; Chung SJ; Kim J; Lim SM; Lee PH; Lee SK; Ahn KJ
    Mov Disord; 2019 Nov; 34(11):1672-1679. PubMed ID: 31322758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
    Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT
    Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter disruption at the prodromal stage of Alzheimer's disease: relationships with hippocampal atrophy and episodic memory performance.
    Rémy F; Vayssière N; Saint-Aubert L; Barbeau E; Pariente J
    Neuroimage Clin; 2015; 7():482-92. PubMed ID: 25685715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage.
    Agosta F; Canu E; Stefanova E; Sarro L; Tomić A; Špica V; Comi G; Kostić VS; Filippi M
    Hum Brain Mapp; 2014 May; 35(5):1921-9. PubMed ID: 23843285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
    Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of a Relation Between Hippocampal Volume, White Matter Hyperintensities, and Cognition in Subjective Cognitive Decline and Mild Cognitive Impairment.
    Caillaud M; Hudon C; Boller B; Brambati S; Duchesne S; Lorrain D; Gagnon JF; Maltezos S; Mellah S; Phillips N; ; Belleville S
    J Gerontol B Psychol Sci Soc Sci; 2020 Aug; 75(7):1382-1392. PubMed ID: 31758692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White-matter changes in early and late stages of mild cognitive impairment.
    Femir-Gurtuna B; Kurt E; Ulasoglu-Yildiz C; Bayram A; Yildirim E; Soncu-Buyukiscan E; Bilgic B
    J Clin Neurosci; 2020 Aug; 78():181-184. PubMed ID: 32334962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of white matter lesions (WML) to Parkinson's disease cognitive impairment symptoms: A critical review of the literature.
    Veselý B; Rektor I
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S166-70. PubMed ID: 26391185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI correlates of episodic memory in Alzheimer's disease, mild cognitive impairment, and healthy aging.
    Sexton CE; Mackay CE; Lonie JA; Bastin ME; Terrière E; O'Carroll RE; Ebmeier KP
    Psychiatry Res; 2010 Oct; 184(1):57-62. PubMed ID: 20832251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE4 and Confluent White Matter Hyperintensities Have a Synergistic Effect on Episodic Memory Impairment in Prodromal Dementia.
    Kumar D; Yatawara C; Wang B; Wong B; Tan YJ; Zailan FZ; Ng KP; Kandiah N
    J Alzheimers Dis; 2022; 87(3):1103-1114. PubMed ID: 35431245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural MRI Correlates of Episodic Memory Processes in Parkinson's Disease Without Mild Cognitive Impairment.
    Pirogovsky-Turk E; Filoteo JV; Litvan I; Harrington DL
    J Parkinsons Dis; 2015; 5(4):971-81. PubMed ID: 26577652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain volumetry in Parkinson's disease with and without dementia: where are the differences?
    Lee SH; Kim SS; Tae WS; Lee SY; Lee KU; Jhoo J
    Acta Radiol; 2013 Jun; 54(5):581-6. PubMed ID: 23474765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.